Graybug Vision Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Graybug Vision Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10690
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Graybug Vision Inc (Graybug Vision) is a clinical stage pharmaceutical company that develops next generation products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company’s lead candidate include GB-102, a clinical-stage depot formulation of sunitinib malatcontains, which is a single small molecule compound that blocks multiple pathogenic angiogenesis pathways included in choroidal neovascularization that causes neovascular or wet age-related macular degeneration. Its pipeline portfolio offers candidates for the treatment of major eye diseases such as glaucoma, retinal vein occlusion, diabetic macular edema, corneal graft rejection, and others. Graybug Vision’s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye. The company operates through its research center located in Baltimore, Maryland, the US. Graybug Vision is headquartered in Redwood City, California, the US.

Graybug Vision Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Graybug Vision Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Graybug Vision Raises USD44.5 Million in Series B Financing 10
GrayBug Raises USD0.7 Million in Financing Round 12
GrayBug Raises USD1.7 Million in Series A2 Financing 13
Graybug Raises USD0.75 Million in Venture Financing 14
Graybug Raises Additional USD0.25 Million in Series A Venture Financing 15
Graybug Raises US$1.2 Million In Venture Financing 16
Licensing Agreements 17
Aerie Pharma Enters into Licensing Agreement with GrayBug 17
GrayBug Enters into Licensing Agreement with Johns Hopkins University 18
Equity Offering 19
GrayBug Raises USD1 Million in Equity Financing 19
Graybug Vision Inc – Key Competitors 20
Graybug Vision Inc – Key Employees 21
Graybug Vision Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
Dec 11, 2017: Graybug Vision Expands Executive Leadership Team with Key Hires 23
Jan 03, 2017: Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer 25
Product News 26
08/08/2017: Graybug Vision CEO to Participate in OIS@ASRS Conference 26
Clinical Trials 27
May 08, 2017: Graybug Vision’s Potential Once-Per-Year AMD Treatment Data Presented at ARVO 2017 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Graybug Vision Inc, Pharmaceuticals & Healthcare, Key Facts 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Graybug Vision Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Graybug Vision Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Graybug Vision Raises USD44.5 Million in Series B Financing 10
GrayBug Raises USD0.7 Million in Financing Round 12
GrayBug Raises USD1.7 Million in Series A2 Financing 13
Graybug Raises USD0.75 Million in Venture Financing 14
Graybug Raises Additional USD0.25 Million in Series A Venture Financing 15
Graybug Raises US$1.2 Million In Venture Financing 16
Aerie Pharma Enters into Licensing Agreement with GrayBug 17
GrayBug Enters into Licensing Agreement with Johns Hopkins University 18
GrayBug Raises USD1 Million in Equity Financing 19
Graybug Vision Inc, Key Competitors 20
Graybug Vision Inc, Key Employees 21
Graybug Vision Inc, Subsidiaries 22

List of Figures
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Graybug Vision Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • Omron Healthcare Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Omron Healthcare Co Ltd (Omron Healthcare), a subsidiary of Omron Corp, is a provider of medical equipment for health monitoring and therapy. The company offers blood pressure monitors, digital thermometers, body fat meters, pedometers, nebulizers, body composition monitors and electric toot …
  • Waters Corporation (WAT)-医療機器分野:企業M&A・提携分析
    Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatograp …
  • TECT Aerospace, Inc.:企業の戦略・SWOT・財務分析
    TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fairfield Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Fairfield Energy Ltd (Fairfield Energy), a subsidiary of Decom Energy Ltd is an oil and gas company that offers oil and gas decommissioning services. The company acquires and develops hydrocarbon properties. It acquires and operates marginal fields in the UK continental shelf. Fairfield Ener …
  • Hanwei Energy Services Corp (HE):企業の財務・戦略的SWOT分析
    Summary Hanwei Energy Services Corp (Hanwei Energy) is a chemical company that develops, manufactures and distributes plastic fibre reinforced piping systems. The company’s products include anhydride and amine cured frp pipes, fittings, fixtures and flanges. It offers client solutions such as pre-te …
  • Symphogen AS:企業の戦略的SWOT分析
    Symphogen AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Peyto Exploration & Development Corp (PEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • Tomophase Corp:製品パイプライン分析
    Summary Tomophase Corp (Tomophase) is a medical device company that offers light-based imaging and therapy solutions. The company develops and commercializes opto-medical devices. It offers endoscopic tissue imaging system based on its proprietary technology optical coherence tomography. Tomophase's …
  • Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Petro Vista Energy Corp (Petro Vista) is an oil and gas company that offers oil and gas exploration and development services. The company offers acquisition, development, exploration, and product …
  • Genedata AG-医療機器分野:企業M&A・提携分析
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Marshall of Cambridge (Holdings) Ltd:戦略・SWOT・企業財務分析
    Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Marshall Aerospace and Defence Group:企業の戦略・SWOT・財務情報
    Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report Summary Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Barry Callebaut AG:企業のM&A・事業提携・投資動向
    Barry Callebaut AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Barry Callebaut AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Theratechnologies Inc (TH):企業の財務・戦略的SWOT分析
    Theratechnologies Inc (TH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • NTN Corp (6472):企業の財務・戦略的SWOT分析
    NTN Corp (6472) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • The Akita Bank Ltd:企業の戦略・SWOT・財務情報
    The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Corporation Bank:企業の戦略・SWOT・財務情報
    Corporation Bank - Strategy, SWOT and Corporate Finance Report Summary Corporation Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • eHealthInsurance Services Inc:企業の戦略的SWOT分析
    eHealthInsurance Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Blue Cross (Asia-Pacific) Insurance Limited:企業の戦略・SWOT・財務情報
    Blue Cross (Asia-Pacific) Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Blue Cross (Asia-Pacific) Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆